Your browser doesn't support javascript.
loading
Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer.
Mortazavi, Deniz; Sohrabi, Behnoush; Mosallaei, Meysam; Nariman-Saleh-Fam, Ziba; Bastami, Milad; Mansoori, Yaser; Daraei, Abdolreza; Zununi Vahed, Sepideh; Navid, Shadan; Saadatian, Zahra; Jamialahmadi, Tannaz; Teng, Yong; Sahebkar, Amirhossein.
Afiliação
  • Mortazavi D; Koç University Research Center for Translational Medicine, Istanbul, Turkey.
  • Sohrabi B; Department of Biology, Faculty of Sciences, Arak University, Arak, Iran.
  • Mosallaei M; Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Nariman-Saleh-Fam Z; Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Bastami M; Non Communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Mansoori Y; Non Communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Daraei A; Department of Medical Genetics, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
  • Zununi Vahed S; Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Navid S; Department of Anatomy, Faculty of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Science, Gonabad, Iran.
  • Saadatian Z; Department of Physiology, Faculty of Medicine, Infectious Diseases Research Center, Gonabad University of Medical Sciences, Gonabad, Iran.
  • Jamialahmadi T; Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Teng Y; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Sahebkar A; Applied Biomedical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
J Oncol ; 2022: 4889807, 2022.
Article em En | MEDLINE | ID: mdl-35087589
ABSTRACT
Cancer is a leading cause of death and disability worldwide. Epigenetic deregulation is one of the most critical mechanisms in carcinogenesis and can be classified into effects on DNA methylation and histone modification. MicroRNAs are small noncoding RNAs involved in fine-tuning their target genes after transcription. Various microRNAs control the expression of histone modifiers and are involved in a variety of cancers. Therefore, overexpression or downregulation of microRNAs can alter cell fate and cause malignancies. In this review, we discuss the role of microRNAs in regulating the histone modification machinery in various cancers, with a focus on the histone-modifying enzymes such as acetylases, deacetylases, methyltransferases, demethylases, kinases, phosphatases, desumoylases, ubiquitinases, and deubiquitinases. Understanding of microRNA-related aberrations underlying histone modifiers in pathogenesis of different cancers can help identify novel therapeutic targets or early detection approaches that allow better management of patients or monitoring of treatment response.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article